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aBsTRacT
INTRODUCTION: Recent studies have described the benefits 
of performing bowel resections for benign and malignant 
diseases as a total laparoscopic procedure with intra-corpo-
real anastomosis. We describe our preliminary experience 
with total laparoscopic surgery for benign lower gastroin-
testinal diseases. 
METHODS: All patients (n = 32) who had received elective 
bowel surgery with intra-corporeal anastomosis for benign 
diseases between November 2013 and August 2015 were 
included in this retrospective study. 
RESULTS: A total of 15 patients (47%) had a primary anasto-
mosis, 17 patients (53%) had a stoma reversal. The median 
length of stay was five days (range: 3-16). Surgical complica-
tions requiring re-operation were present in five patients 
(Clavien-Dindo grade IIIb) of whom two presented with 
anastomotic leaks (6%; 95% confidence interval: 2-20%). No 
post-operative medical complications according to the Cla-
vien-Dindo Classification were seen. The median duration of 
surgery was 127 minutes (range: 61-211 min.). No deaths 
occurred. 
CONCLUSION: A total laparoscopic approach to benign  
lower gastrointestinal diseases with intra-corporeal ana-
stomosis was feasible. 
FUNDING: none.
TRIAL REGISTRATION: The trial is registered with the Danish 
Data Protection Agency.
 
Several studies have proven the benefits of laparoscopic 
bowel resection compared with open or hand-assisted 
surgery. Recent studies have highlighted the feasibility 
[1, 2] and the benefit [3] of performing a complete lapa-
roscopic procedure with total intra-corporeal anastomo-
sis (IA) compared with an extra-corporeal anastomosis 
(EA). A large study with 105 patients who underwent 
large bowel resection for benign and malignant disease 
showed an earlier recovery of bowel function, a lower 
need for analgesics and a shorter hospital stay in the IA 
group [4]. One of the reasons is believed to be the op-
tion to create a shorter and more optimal incision site 
for extraction of the specimen.
A primary challenge with the extracorporeal ana-
stomosis is the need for externalisation of the bowel in 
order to perform the anastomosis; this procedure  
causes longer incisions and added tension to the mes-
entery and its arteries. The latter might entail an in-
creased risk of portal vein thrombosis and mesenteric 
vascular occlusion [5, 6]. Especially in patients with a 
short mesentery, i.e. obese patients or patients with in-
flamed bowel and/or thickened mesentery, this can re-
sult in a need for conversion to open surgery. 
Here we describe our preliminary experience with 
total laparoscopic resection and IA in patients undergo-
ing elective benign large and small bowel surgery.
mEThOds
All patients who had an IA during elective surgery for a 
benign disease from November 2013 to August 2015 
were included in the study. All malignancies and/or 
acute and emergency surgeries were excluded. Data 
were extracted from our electronic medical reports and 
the anaesthesia charts. All patients had a minimum fol-
low-up of 30 days.
The decision to perform a primary anastomosis ver-
sus a stoma was made intra-operatively by the leading 
surgeon, depending on the amount of bowel inflamma-
tion, fistulation and whether or not peritonitis or pre-
stenotic bowel dilatation was found. When we decided 
to perform an anastomosis, we always opted for IA  
rather than EA. We did not defer from performing an IA 
on indication of the patient’s risk profile (comorbidities, 
etc.). In our patient group with stoma reversal where we 
were able to access the peritoneal cavity laparoscopical-
ly, we always opted for IA. Thus, our population is repre-
sentative of the normal patient population receiving  
laparoscopic surgery for benign diseases. 
All anastomoses were performed as side-to-side  
in an iso-peristaltic fashion, with either an Echelon 
Endopath linear stapler (Ethicon, USA) or the electronic 
iDrive stapler (Covidien), using a 60 mm linear cartridge 
for both (Figure 1A). The enterotomy was closed with a 
15-cm continuous self-locking V-Loc (Covidien) suture  
in the transverse direction in two layers, or Vicryl 3-0 
(Ethicon, USA) running suture in the longitudinal direc-
tion in two layers (Figure 1B). Specimen extraction was 
mainly done through a small muscle-sparring Pfannel-
stiel incision (57%), alternatively through previous inci-
sions (29%), an Endobag (7%) or a lower midline incision 
(7%). The surgeons did not record the length of the inci-
sion. 
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All procedures were performed by one of two staff 
surgeons: one specialised in inflammatory bowel disease 
(IBD) surgery and minimally invasive surgery, and the 
other specialised in gastric bypass surgery with an expe-
rience of 250 Roux-en-Y gastric bypass procedures.  
A junior or senior resident was assigned as the staff sur-
geon’s assistant. 
The following data were recorded: age, sex, Ameri-
can Society of Anesthesiologists (ASA) score, body mass 
index, smoking, diabetes, hypertension, cardiovascular 
disease, chronic obstructive pulmonary disease, asthma, 
IBD or gastro-intestinal malignancy. We also recorded 
whether a primary anastomosis or a stoma reversal was 
performed. Further-more, the use of V-Loc or Vicryl was 
registered along with the type of anastomosis and the 
main surgeon on the case as well as operating time, 
length of hospital stay (LOS) and post-operative surgical 
and medical complications according to the Clavien-
Dindo classification. 
Data are presented as medians with interquartile 
range, range and percentages. Incidences are presented 
as number (% with 95% confidence interval (CI). Data 
were analysed using SPSS (IBM, USA, Vers. 22). The data 
collection was approved by the Danish Data Protection 
Agency.
Trial registration: The trial is registered with the Danish 
Data Protection Agency.
REsUlTs
In all, 32 patients were included during the 21-month 
trial period. Patient demographics are presented in Ta-
ble 1. The majority of our patients, 22 (69%), suffered 
from IBD.
A total of 15 (47%) of our patients were on either 
low-dose systemic steroid (< 20 mg a day) or immuno-
modulation (adalimumab (Humira) or infliximab (Remi-
cade) < 30 days before the surgery. 
Surgical characteristics are presented in Table 2.  
A total of 17 patients (53%) had stoma reversal. Among 
them, seven had undergone a previous laparoscopic 
bowel resection and ten had undergone a previous open 
bowel resection. All stomas in our population were fash-
ioned as an end-stoma with the efferent bowel remain-
ing as a blind loop intra-abdominally. The remaining 15 
patients (47%) (out of 32 patients) had a resection with 
primary anastomosis. More than two thirds, 22 patients 
(69%), were ileo-ascending anastomoses. Ileo-jejunal 
anastomoses and ileo-transverse anastomoses made up 
the remainder of the procedures, equaling a total of five 
patients (16%). A V-loc was used in the majority of the 
anastomoses (27 patients, 84%). Post-operative data are 
shown in Table 3. 
Our median LOS was five days (range: 3-16 days), 
with a single patient staying 16 days due to early recog-
nised anastomotic leakage and peritonitis necessitating 
further surgery.
Five patients (16%; 95% CI: 7%-32%) underwent re-
laparoscopy on suspicion of anastomotic leak. Two pa-
tients (6%; 95% CI: 2%-20%) had a small anastomotic 
leak and one patient had 500 ml blood in the abdomen 
from a port-site bleeding. The two remaining patients 
had normal findings at re-laparoscopy.
None of the three patients (9%; 95% CI: 3%-24%) 
with no evidence of anastomotic leakage on re-laparo-
scopy received any further surgical interventions, but 
were treated with intra-venous antibiotics and discharged 
few days after their second operation. With respect to 
complications, besides the five Grade IIIb complications 
mentioned above, we saw no further complications that 
deviated from the normal post-operative course. There 
were no deaths within 30 days after surgery.
FigURE 1
a. The intra-corporeal  
stapling of the anastomo-
sis using a linear laparo-
scopic stapler. B. The  
intra-corporeal suturing 
of the enterotomy using 
the self-locking V-Loc  
(Covidien) suture.
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discUssiOn
In this study, we observed that use of IA for benign  
lower gastrointestinal surgery is feasible and safe. How-
ever, the current literature on this subject is sparse, and 
further studies with larger sets of patients are required 
to fully highlight this issue.
Several articles have discussed the benefits of a to-
tal laparoscopic approach to bowel resection [1-5, 7-9]. 
Most current literature deals with colonic resection in 
cancer surgery, and especially with right-sided hemi-
colectomies, or Roux-en-Y gastric bypass surgery. 
Regarding anastomotic leakages, previous reports 
have shown similar rates of leakage between IA and EA 
in both benign and malignant colorectal surgery [7, 10]. 
A review from 2013 of 13 studies comprising a total of 
611 cases described a leakage rate of 1% (range: 0-8.5%) 
and a rate of re-operations of 0.8% (range: 0-25%) [8]. In 
our study, we found five patients (16%; 95% CI: 7%-32%) 
with post-operative surgical complications, all within 
eight days of their primary operation (range: 3-8 days). 
Not all of our patients had a significant rise in C-reactive 
protein on the day of their re-operation (range: 28-275), 
but were re-operated on clinical and radiological suspi-
cion of surgical complications. The high percentage of 
post-operative complications in our population may be 
due to the small number of patients and can therefore 
not be subjected for in statistical analysis. A larger group 
size is necessary to produce valid data on the percent-
age of postoperative surgical complications in this popu-
lation.  
When looking at surgery for colorectal cancer, com-
paring midline incision to laparoscopic procedures with 
non-midline extraction sites, we observed a reduction in 
the risk of incisional hernias from 12.9% to 2.4% [11].  
A Cochrane review described a non-significant differ-
ence of 7.9% versus 10.9% in laparoscopic assisted ver-
sus open surgery [12]. As the incidence of port site her-
nias in total laparoscopic procedures is as low as 0.5%, 
possibly even lower when suturing the fascia of port 
sites > 10 mm [13], it seems plausible that there would 
be a benefit in performing total IA rather than  EA. 
The benefits of an IA described in colorectal surgery 
are sure to be the same in small bowel surgery, and the 
risk of stenosis is theoretically small with transversal su-
turing of the enterotomy [14]. 
One claim against IA in the earlier years was the in-
creased operating room (OR) time, which was attributed 
mainly to the difficulty of laparoscopic suturing. How-
ever, it remains to be shown if the actual duration of 
surgery is longer when technical advances, i.e. self-hold-
ing sutures, electronic staplers, etc., are taken into ac-
count. Furthermore, performing an IA with less tension, 
less dissection and smaller incisions may also influence 
the OR time positively; in fact, a retrospective study of 
100 patients found a shorter mean OR time in the total 
laparoscopic group than in laparoscopic assisted right 
hemi-colectomies [9]. One clear advantage of IA over  
EA is that the surgeon does not have to externalise  
the bowel to perform the anastomosis. Especially in 
obese patients or other patients with a shortened  
mesentery this could create an increased risk for conver-
sion to open surgery. We had no conversions in our 
dataset. 
TaBlE 3
Postsurgical characteristics.
Length of stay, days, median (range) 5 (3-16)
Post-operative medical complications, n 0
Post-operative surgical complications, n (%; 95% CI)
Negative re-laparoscopy 3 (9; 3-24)
Anastomotic leak 2 (6; 2-20)
Total 5 (16; 7-32)
CI = confidence interval.
TaBlE 2
Surgical characteristics.
Primary anastomosis, n (%) 15 (47)
Stoma reversal, n (%) 17 (53)
V-Loc, n (%) 27 (84)
Ileo-ileo anastomosis, n (%) 5 (16)
Ileo-transversal anastomosis, n (%) 5 (16)
Ileo-ascending anastomosis, n (%) 22 (69)
OR time, min., median (range) 127 (61-211)
OR = operation.
TaBlE 1
Baseline patient characteristics.
Age, yrs, median (range) 42 (20-73)
Male sex, n (%) 10 (31)
ASA score, median (range) 2 (1-3)
BMI, kg/m2, median (range) 25 (16-40)
Inflammatory bowel disease, n (%) 22 (69)
Diabetes, n (%) 2 (6)
Hypertension, n (%) 6 (19)
CVD, n (%) 2 (6)
COPD/asthma, n (%) 3 (9)
Pre OP systemic steroid, n (%) 3 (9)
Pre OP immunomodulation, n (%) 12 (38)
Smoker, n (%) 8 (25)
ASA = American Society of Anesthesiologists; BMI = body mass 
index; COPD = chronic obstructive pulmonary disease; CVD = 
cardiovascular disease; Pre OP = preoperative.
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cOnclUsiOn
Our data show that a total laparoscopic approach with 
IA is a feasible technique in entero-entero anastomoses 
in benign diseases. 
cORREsPOndEncE: Jacob Antonsen. E-mail: jacobantonsen@dadlnet.dk
accEPTEd: 15 August 2017
cOnFlicTs OF inTEREsT: Disclosure forms provided by the authors are 
available with the full text of this article at www.danmedj.dk
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